Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aziza Nassar

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Breast Cancer Research and Treatment|July 29, 2017
Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involutionMelody L Stallings-Mann, Ethan P Heinzen, Robert A Vierkant, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 2009
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigenLavakumar Karyampudi, Christopher J Krco, Kimberly R Kalli, et al.
Oncotarget|October 6, 2015
Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancersChristine Mehner, Ann L Oberg, Kimberly R Kalli, et al.
The Breast Journal|June 24, 2026
HER2-Ultralow: Prevalence, Characteristics, and Treatment Choices Among Advanced Breast Cancer Patients With Tumors Initially Scored as IHC 0Anushree R Iyengar, Erinn P Downs, Sandhya Mehta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Novel breast tissue feature strongly associated with risk of breast cancerKevin P McKian, Carol A Reynolds, Daniel W Visscher, et al.
Thyroid : Official Journal of the American Thyroid Association|January 25, 2017
American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear FeaturesBryan R Haugen, Anna M Sawka, Erik K Alexander, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|February 1, 2021
Addressing the Challenge of COVID-19: One Health Care Site's Leadership Response to the PandemicChristina K Zorn, Jorge M Pascual, Wendelyn Bosch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2025
A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast CancerKeith L Knutson, Hala Abu-Fares, Patricia Keating, et al.
Breast Cancer Research and Treatment|August 12, 2017
NanoString-based breast cancer risk prediction for women with sclerosing adenosisStacey J Winham, Christine Mehner, Ethan P Heinzen, et al.
NPJ Breast Cancer|February 13, 2020
Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patientsNadine Norton, Bahaaeldin Youssef, David W Hillman, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Breast Cancer Research and Treatment|July 29, 2017
Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involutionMelody L Stallings-Mann, Ethan P Heinzen, Robert A Vierkant, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 2009
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigenLavakumar Karyampudi, Christopher J Krco, Kimberly R Kalli, et al.
Oncotarget|October 6, 2015
Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancersChristine Mehner, Ann L Oberg, Kimberly R Kalli, et al.
The Breast Journal|June 24, 2026
HER2-Ultralow: Prevalence, Characteristics, and Treatment Choices Among Advanced Breast Cancer Patients With Tumors Initially Scored as IHC 0Anushree R Iyengar, Erinn P Downs, Sandhya Mehta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Novel breast tissue feature strongly associated with risk of breast cancerKevin P McKian, Carol A Reynolds, Daniel W Visscher, et al.
Thyroid : Official Journal of the American Thyroid Association|January 25, 2017
American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear FeaturesBryan R Haugen, Anna M Sawka, Erik K Alexander, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|February 1, 2021
Addressing the Challenge of COVID-19: One Health Care Site's Leadership Response to the PandemicChristina K Zorn, Jorge M Pascual, Wendelyn Bosch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2025
A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast CancerKeith L Knutson, Hala Abu-Fares, Patricia Keating, et al.
Breast Cancer Research and Treatment|August 12, 2017
NanoString-based breast cancer risk prediction for women with sclerosing adenosisStacey J Winham, Christine Mehner, Ethan P Heinzen, et al.
NPJ Breast Cancer|February 13, 2020
Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patientsNadine Norton, Bahaaeldin Youssef, David W Hillman, et al.
Pageof 15